Welcome to RealPharma!
RealPharma
RealPharma
For biopharma pros seeking insightful discussions and a deeper understanding of the pharma world, join Dr. Na-Ri Oh and Ian Wendt as they talk with industry leaders and luminaries to delve into biotechnology, pharmaceuticals, and healthcare. RealPharma podcast aims to challenge your viewpoints, deepen your understanding of the pharma world beyond the headlines, and explore emerging trends in medical innovation.
Choose your favorite podcast player
RealPharma

RealPharma

For biopharma pros seeking insightful discussions and a deeper understanding of the pharma world, join Dr. Na-Ri Oh and Ian Wendt as they talk with industry leaders and luminaries to delve into biotechnology, pharmaceuticals, and healthcare.

RealPharma podcast aims to challenge your viewpoints, deepen your understanding of the pharma world beyond the headlines, and explore emerging trends in medical innovation.

The player is loading ...
Can We Say That? Dara Katcher Levy on the AdPromo Regulatory Landscape

Recent Episodes

Aug. 25, 2025

Can We Say That? Dara Katcher Levy on the AdPromo Regulatory Landscape

In this episode of RealPharma, Ian Wendt and Na-Ri Oh sit down with Dara Katcher Levy, a regulatory attorney at Hyman, Phelps & McNamara, P.C. —widely regarded as one of the nation’s top firms in food and drug law. Dara bring...

Listen to the Episode
Aug. 11, 2025

From Rock Star to Rare Disease Revolutionary: Casey McPherson’s Fight…

Episode Title: From Rock Star to Rare Disease Revolutionary: Casey McPherson’s Fight for His Daughter’s Life In this deeply personal and inspiring conversation, hosts Na-Ri Oh and Ian Wendt sit down with Casey McPherson, foun...

Listen to the Episode
July 28, 2025

Behind the PBM Curtain: Antonio Ciaccia Exposes the Game

Episode Title: Behind the PBM Curtain: Antonio Ciaccia Exposes the Game Show Notes: In this compelling episode of Real Pharma , hosts Na-Ri Oh and Ian Wendt welcome back Antonio Ciaccia, CEO of 46brooklyn Research and Preside...

Listen to the Episode
July 14, 2025

340B or Bust: Is This Program Failing the Sick

🎙️ 340B or Bust: Is This Program Failing the Sick? This week on Real Pharma, hosts Dr. Na-Ri Oh and Ian Wendt dive into the tangled world of 340B with returning guest William “Bill” Sarraille—one of the most respected voices ...

Listen to the Episode
June 30, 2025

Paging Dr. ChatGPT with Bryce Sady

Episode Title: Paging Dr. ChaptGPT with Bryce Sady AI Adoption in Healthcare: Navigating the Present and Shaping the Future with Bryce Sady Episode Description: On today's insightful episode of RealPharma, hosts Dr. Na-Ri Oh ...

Listen to the Episode
June 16, 2025

Hiring Heat Check: What’s Hot in Biotech + Pharma Talent in Mid-2025

Episode Title: “Hiring Heat Check: What’s Hot in Biotech + Pharma Talent in Mid-2025” 🎙️ Hosts: Ian Wendt & Na-Ri Oh 🎧 Guest: Kristiaan Rawlings, Executive Recruiter at EPM Scientific Episode Overview: This week, fan favorite...

Listen to the Episode

About the Hosts

Dr. Na-Ri Oh Profile Photo

Dr. Na-Ri Oh

As an innovative biopharmaceutical leader with a medical background in Infectious Diseases, Na-Ri Oh, MD brings a unique blend of clinical and business acumen to the table. Na-Ri has held a wide variety of commercial and strategy leadership roles in multiple pharmaceutical companies. Nari has over two decades of experience in clinical patient care and research as well as leading global marketing and strategic planning initiatives, particularly in the areas of HIV, viral hepatitis, and liver disease. Na-Ri is especially passionate about global public health and alternative commercialization models in emerging markets.

Ian Wendt Profile Photo

Ian Wendt

Ian Wendt has over three decades of experience in the biotechnology and pharmaceutical sectors. Ian is currently serving as the Chief Commercial Officer at an emerging biotechnology company. Prior to his current role, Ian has held leadership positions at a variety of large pharmaceutical companies leading national teams and driving market development outcomes in HIV treatment and prevention, and hepatitis C. His expertise spans business strategy, revenue and profit growth, and cross-functional leadership, making him a sought-after voice in the industry.